SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
130.20    2.40 (1.88%)
Bid:
130.00
Ask:
130.40
Spread: 0.40 (0.308%)
Market Cap: £268.15m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Board Changes

10 Dec 2019 07:00

RNS Number : 2749W
Forterra plc
10 December 2019
 

10 December 2019

 

Forterra plc

Board Changes

 

Forterra plc ("Forterra" or the "Company") announces that Shatish Dasani is stepping down from his role as Chief Financial Officer and as a Director of the Board on 31 December 2019 to pursue other opportunities. Forterra also announces that Ben Guyatt will be appointed as Chief Financial Officer on 1 January 2020 and will join the Board of Forterra at that point.

 

Shatish Dasani joined Forterra in December 2015 and was a key member of the leadership team which successfully took the Company through the IPO in April 2016 and implemented the strategy to drive value for shareholders. In his time with Forterra, he has overseen a significant deleveraging and strengthening of its balance sheet, whilst investing in the core businesses and following a progressive dividend policy.

 

Ben Guyatt has served as Director of Finance and Company Secretary of Forterra since its listing in April 2016 and, prior to this, he was Finance Director of the business at the time of its divestment by HeidelbergCement in 2015. Ben joined Hanson plc in 2006 and held a variety of senior finance and strategy roles within Hanson and HeidelbergCement. Previously Ben held financial management roles at Heath Lambert. The Board believes that Ben will bring a deep and valuable knowledge of Forterra, and the wider market, to the Board.

 

Justin Atkinson, Chairman, commented:

 

"On behalf of the Board I would like to thank Shatish for his substantial contribution to the Company over the last four years and wish him well in the next stage of his career.

 

"I am delighted that Ben will be joining the Board as Chief Financial Officer. Having worked with Ben since the successful IPO, I am convinced he will bring significant knowledge and experience to the Board."

 

Shatish Dasani commented:

 

"I have enjoyed tremendously my time at Forterra and would like to thank the Board and all members of staff for their support. I leave the Group in a strong financial and strategic position, with great potential to continue delivering value for all stakeholders. After four years with the Group, I believe that this is the right time for me to pursue other career opportunities. I wish the team well as they take the business on the next stage of its development."

 

 

Enquiries

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain

Nick Hasell

 

 

The Company confirms that there are no other disclosures to be made in connection with Ben Guyatt's appointment under LR 9.6.13R of the Listing Rules.

 

Shatish Dasani's leaving arrangements have been determined in accordance with our Directors' Remuneration Policy. The statement required by s.430 (2B) of the Companies Act 2006 will be made available for shareholders on the Company's website as soon as reasonably practicable following the date on which Mr Dasani ceases to be a Director.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAVKLFBKLFEFBX
Date   Source Headline
20th Jan 20267:00 amRNSEmployee Benefit Trust Share Purchase
7th Jan 20269:39 amRNSEmployee Benefit Trust Share Purchase
2nd Dec 20259:22 amRNSEmployee Benefit Trust Share Purchase
24th Nov 20259:03 amRNSHolding(s) in Company
20th Nov 20259:13 amRNSHolding(s) in Company
18th Nov 20255:03 pmRNSEmployee Benefit Trust Share Purchase
11th Nov 20257:00 amRNSTrading Update
4th Nov 20254:34 pmRNSEmployee Benefit Trust Share Purchase
24th Oct 20251:36 pmRNSHolding(s) in Company
23rd Oct 20251:21 pmRNSDirector/PDMR Shareholding
17th Oct 20259:58 amRNSEmployee Benefit Trust Share Purchase
14th Oct 20259:06 amRNSHolding(s) in Company
13th Oct 202510:15 amRNSEmployee Benefit Trust Share Purchase
2nd Oct 20252:54 pmRNSGrant of Options under 2025 SAYE Scheme
11th Aug 20251:15 pmRNSHolding(s) in Company
29th Jul 20257:38 amRNS-RProgressive publishes new research
29th Jul 20257:00 amRNSSix months ended 30 June 2025
23rd Jul 202510:05 amRNSHolding(s) in Company
19th Jun 20257:05 amRNSDirector Declaration
20th May 20251:47 pmRNSAnnual General Meeting 2025 Results
20th May 20257:43 amRNS-RProgressive publishes new research
20th May 20257:00 amRNSAGM Trading Update
13th May 202510:36 amRNSHolding(s) in Company
11th Apr 20259:18 amRNSDirector / PCA Shareholdings
2nd Apr 20252:22 pmRNSDirector/PDMR Shareholding
26th Mar 20255:53 pmRNSAnnual Report & Accounts 2024 & Notice of AGM 2025
25th Mar 20251:47 pmRNSDirector/PDMR Shareholding
20th Mar 20252:44 pmRNSHolding(s) in Company
20th Mar 20257:00 amRNSGrant under Performance Share Plan
20th Mar 20257:00 amRNSGrant under Deferred Annual Bonus Plan
18th Mar 20252:23 pmRNSHolding(s) in Company
12th Mar 20258:14 amRNS-RProgressive publishes new research
12th Mar 20257:00 amRNSFull Year Results
6th Mar 20257:00 amRNSAppointment of Independent Non-Executive Director
27th Feb 20253:35 pmRNSHolding(s) in Company
26th Feb 20252:50 pmRNSHolding(s) in Company
4th Feb 20257:00 amRNSDirectorate Change
23rd Jan 20257:00 amRNSFull Year 2024 Trading Update
6th Jan 20259:23 amRNSHolding(s) in Company
2nd Jan 202511:38 amRNSDirector/PDMR Shareholding
11th Nov 20247:00 amRNSTrading update to the end of the October
4th Nov 202410:24 amRNSHolding(s) in Company
30th Oct 20244:54 pmRNSHolding(s) in Company
28th Oct 202411:51 amRNSHolding(s) in Company
2nd Oct 20245:35 pmRNSGrant of Options under 2024 SAYE Scheme
11th Sep 20247:00 amRNSDirectorate Change
5th Sep 202411:49 amRNSHolding(s) in Company
2nd Sep 20249:59 amRNSHolding(s) in Company
12th Aug 20243:03 pmRNSHolding(s) in Company
30th Jul 20247:00 amRNSSix months ended 30 June 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.